Portal vein-enriched metabolites as intermediate regulators of the gut microbiome in insulin resistance
Cell Metabolism · 2025
DOI: 10.1016/j.cmet.2025.08.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Metabolism, 2025. Verfasst von Vitor Rosetto Muñoz und 17 weiteren Autor:innen. Beteiligte Einrichtung: Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Insulin Resistance, Gastrointestinal Microbiome, Portal Vein. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIMHD NIH HHS.
Abstract (Originalsprache)
Diet and obesity contribute to insulin resistance and type 2 diabetes, in part via the gut microbiome. To explore the role of gut-derived metabolites in this process, we assessed portal/peripheral blood metabolites in mice with different risks of obesity/diabetes, challenged with a high-fat diet (HFD) + antibiotics. In diabetes/obesity-prone C57BL/6J mice, 111 metabolites were portally enriched and 74 were peripherally enriched, many of which differed in metabolic-syndrome-resistant 129S1/129S6 mice. Vancomycin treatment of HFD-fed C57BL/6J mice modified the microbiome and the portal/peripheral ratio of many metabolites, including upregulating tricarboxylic acid (TCA) cycle-related metabolites, like mesaconate, in portal blood. Treatment of isolated hepatocytes with mesaconate, itaconate, or citraconate improved insulin signaling and transcriptionally regulated genes involved in gluconeogenesis, fatty acid oxidation, and lipogenesis in vitro and in vivo. In humans, citraconate levels are inversely correlated with plasma glucose. Thus, portal versus peripheral metabolites play important roles in mediating effects of the microbiome on hepatic metabolism and the pathogenesis of HFD-related insulin resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
- Section on Pathophysiology and Molecular Pharmacology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
- Biology Department Boston College, Chestnut Hill, MA, USA.
- Metabolomics Platform, Broad Institute of MIT and Harvard University, Cambridge, MA, USA.
- Bioinformatics and Biostatistics Core, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
- Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIMHD NIH HHS
- National Institute on Minority Health and Health Disparities
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- Jackson State University
- National Heart, Lung, and Blood Institute
Zitieren
APA
Muñoz, V. R., Moreau, F., Soto, M., Watanabe, Y., Pham, L. D., Zhong, J., Zimmerman, S., Brandao, B. B., Girdhar, K., Avila, J., Pan, H., Dreyfuss, J. M., Mi, M. Y., Gerszten, R. E., Altindis, E., Kostic, A., Clish, C. B., & Kahn, C. R. (2025). Portal vein-enriched metabolites as intermediate regulators of the gut microbiome in insulin resistance. Cell Metabolism. https://doi.org/10.1016/j.cmet.2025.08.005
Vancouver
Muñoz VR, Moreau F, Soto M, Watanabe Y, Pham LD, Zhong J, et al. Portal vein-enriched metabolites as intermediate regulators of the gut microbiome in insulin resistance. Cell Metabolism. 2025. doi:10.1016/j.cmet.2025.08.005
BibTeX
@article{Muoz2025,
author = {Muñoz, Vitor Rosetto and Moreau, Francois and Soto, Marion and Watanabe, Yoshiyuki and Pham, Loc-Duyen and Zhong, Jimmy and Zimmerman, Sam and Brandao, Bruna B and Girdhar, Khyati and Avila, Julian and Pan, Hui and Dreyfuss, Jonathan M and Mi, Michael Y and Gerszten, Robert E and Altindis, Emrah and Kostic, Aleksandar and Clish, Clary B and Kahn, C Ronald},
title = {Portal vein-enriched metabolites as intermediate regulators of the gut microbiome in insulin resistance},
journal = {Cell Metabolism},
year = {2025},
doi = {10.1016/j.cmet.2025.08.005}
}
EUVIMED